USC has joined a coalition of 15 leading research universities that aims to boost the transfer of researchers’ patented technologies and inventions to companies.
Epic Sciences and USC Michelson Center Convergent Science Institute in Cancer recently announced a new partnership. The Stevens Center helped Dr. Peter Kuhn with the process of executing the license and collaboration agreement.
Bravemind is a clinical, interactive, virtual reality (VR) based exposure therapy tool being used to assess and treat post-traumatic stress disorder (PTSD).
Dr. Mark E. Thompson with his collaborators at USC and Princeton University developed organic light-emitting diode (OLED) technology that Universal Display Corporation (UDC) has advanced and commercialized into an international business.
Dr. Paul Debevec and collaborators created the Light Stages to make believable digital doubles for movies, television, video games and immersive simulations by capturing and simulating how objects and people reflect any possible lighting.
The Argus II Retinal Prosthesis system is the first FDA-approved implanted electronic device to re-establish some functional vision in blind patients.